Sep 2026· Annals of Laboratory Medicine· 0 citations
Medicine
TL;DR
The TF-OSLM framework is readily transferable to other high-volume clinical chemistry tests, and stewardship programs should incorporate prospective evaluation of clinical outcomes alongside utilization metrics to build a comprehensive evidence base for outcome-based quality in laboratory medicine.
Abstract
Stewardship of laboratory services aims to ensure appropriate test utilization and improve patient outcomes. However, clinical chemistry initiatives have largely focused on reducing test volumes and costs rather than linking interventions to clinical outcomes. This review examines stewardship strategies for clinical chemistry tests using an outcome-based framework developed by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Task Force on Outcome Studies in Laboratory Medicine (TF-OSLM), which classifies outcomes into seven categories: change in patient management, clinical outcomes, economics, operational efficiencies, patient-centeredness, safety, and guide policy making. We review stewardship evidence for three high-impact targets: erythrocyte sedimentation rate/C-reactive protein co-ordering, cardiac troponin with legacy markers, and vitamin D testing. For each target, we summarize the clinical context, intervention strategies, and outcomes mapped to the TF-OSLM framework. Across all three targets, strong evidence supports reductions in test volume and associated cost savings at the institutional and national levels. However, a consistent gap emerges: direct evidence linking these interventions to patient-level clinical outcomes, such as mortality or diagnostic trajectories, remains limited. Safety data remain limited to retrospective observations, and most evidence stems from large academic centers. Public demand for testing, driven by media and wellness culture, poses an additional challenge that can undermine even robust policy interventions. The TF-OSLM framework is readily transferable to other high-volume clinical chemistry tests, and stewardship programs should incorporate prospective evaluation of clinical outcomes alongside utilization metrics to build a comprehensive evidence base for outcome-based quality in laboratory medicine.
A multidisciplinary mortality review committee at a large urban teaching hospital successfully implementing a multidisciplinary mortality review committee that drives accountability and quality improvement demonstrated its growing impact as a driver of accountability and system-level quality improvement.
K. Cools, Theresa Zatirka, A. Feldman et al.· JCO Oncology Practice· 0 citations
A structured, standards-aligned development pathway can strengthen the trustworthiness of scores and the clinical utility of instruments used in high-acuity care, supporting well-evidenced decisions across research and practice.
Michael J. Ireland, S. A. Weerasinghe, Rohan De Pallant et al.· Australian Critical Care· 0 citations
Abstract Excessive laboratory investigations in the intensive care units (ICUs) contribute to increased risk of line infections, iatrogenic anaemia, environmental burden and healthcare costs without clear mortality benefit. Despite Choosing Wisely recommendations advocating clinically indicated testing, overutilisation...
C. Yeo, Si-Ting Goh, Ren-Ci Zeng et al.· BMJ Open Quality· 0 citations
Background and objective Reducing low-value care may improve clinical practice and preserve scarce resources, but lower use alone does not demonstrate better allocation. We examined how selected African studies define inappropriate care, assess whether patients receive needed care, and report resource consequences and...
Arnold Atuhaire, N. Charles, Babirye Shamim et al.· F1000Research· 0 citations
In 2024, the Cincinnati Children’s Hospital Medical Center (CCHMC) Clinical Laboratories established the Laboratory Value Analysis Committee (LVAC) to develop evidence based, clinically sound, and financially responsible plans that support safe, effective, and value-added clinical laboratory testing while still m...
Background: Antimicrobial resistance (AMR) is sustained not only by inappropriate antimicrobial use but also by diagnostic failure. Unnecessary testing can trigger treatment of colonization or contamination, whereas absent, delayed, or poorly communicated testing encourages prolonged empirical broad-spectrum therapy. D...